JavaScript is disabled. Please enable to continue!

Mobile search icon
Media Centre >> Press Releases 2014 >> 2014-03-26

Eurofins Eaton Analytical expands its US water testing footprint with the acquisition of UL’s Water Testing Business

Sidebar Image

Eurofins Eaton Analytical, Inc. (EEA), the largest potable water testing laboratory in theUS, announces that it has signed an agreement to acquire the consumer and municipal water testing business of UL (Underwriters Laboratories). The transaction is expected to close no later than April 30.

With nearly 40 years as a leading provider of water quality analytical services, UL's water testing laboratory is certified to perform drinking water analyses in all 50 states. The 70,000 square-foot state-of-the-art laboratory employs 70 staff and generates revenues of over US $8m. The laboratory has the second highest volume of US Environmental Protection Agency (EPA) Unregulated Contaminant Monitoring Rule 3 (UCMR3) program contracts, after Eurofins Eaton Analytical (EEA). Therefore, with this acquisition, EEA reinforces its position as the premier laboratory in the US serving the UCMR3 needs of the EPA.

Located in South Bend,IN, the laboratory serves more than 7,000 state and local municipalities as well as bottlers, engineering firms, consultants and federal agencies such as the EPA and US Military.  From comprehensive Safe Drinking Water Act (SDWA) compliance services to cutting-edge capabilities that analyze trace levels of emerging contaminants, UL's water testing laboratory offers a comprehensive range of analytical testing services, including microbiology, chemistry and radiochemistry.

Eurofins recognizes water quality to be critical for public health protection, whether in public water supplies or as a component of food and beverages, and with the continued interest in emerging contaminants and the development of ever more stringent standards, this acquisition provides clients with a trusted laboratory partner that can respond to their needs 24/7 from multiple convenient service centers.

"Combining the two leading drinking water laboratories strategically enhances our US Environmental Testing business' position at the industry's forefront for water quality testing and technical leadership," says Keith Wheatstone, Ph.D., President, Eurofins Environment Testing US.

For more information, please visit www.eatonanalytical.com or contact:

Andy Eaton,

VP Eurofins Eaton Analytical

Phone: +1 626 386 1100

E-mail: andyeaton@eurofinsus.com

Michelle Press

UL Global Marketing Communications Manager

Phone : +1 847 664 1966

Michelle.Press@ul.com

Notes for the editor:

About Eurofins Eaton Analytical

Eurofins Eaton Analytical (EEA) is the largest potable water testing laboratory in the United States, serving water quality professionals worldwide, with clients throughout the United Statesand more than 100 countries worldwide. The company's 39,000-square-foot analytical testing facility is located in Monrovia, Calif., where more than 120 leading chemists, microbiologists and scientists are employed. For more information, please visit www.eatonanalytical.com or e-mail: us20_sales@eurofinsus.com.

About UL

UL is a premier global independent safety science company that has championed progress for 120 years. Its more than 10,000 professionals are guided by the UL mission to promote safe working and living environments for all people. UL uses research and standards to continually advance and meet ever-evolving safety needs. We partner with businesses, manufacturers, trade associations and international regulatory authorities to bring solutions to a more complex global supply chain. For more information about our certification, testing, inspection, advisory and education services, visit http://www.ul.com

About Eurofins Scientific

Eurofins - a global leader in bio-analysis

Eurofins Scientific is the world leader in food and pharmaceutical products testing. It is also number one in the world in the field of environmental laboratory services and one of the global market leaders in agroscience, genomics, discovery pharmacology and central laboratory services.

With about 15,000 staff in more than 190 laboratories across 36 countries, Eurofins offers a portfolio of over 100,000 reliable analytical methods for evaluating the safety, identity, composition, authenticity, origin and purity of biological substances and products. The Group provides its customers with high-quality services, accurate results in time and expert advice by its highly qualified staff.

Eurofins is committed to pursuing its dynamic growth strategy by expanding both its technology portfolio and its geographic reach. Through R&D and acquisitions, the Group draws on the latest developments in the field of biotechnology and analytical chemistry to offer its clients unique analytical solutions and the most comprehensive range of testing methods.

As one of the most innovative and quality oriented international players in its industry, Eurofins is ideally positioned to support its clients' increasingly stringent quality and safety standards and the expanding demands of regulatory authorities around the world.

The shares of Eurofins Scientific are listed on the NYSE Euronext Paris Stock Exchange (ISIN FR0000038259, Reuters EUFI.PA, Bloomberg ERF FP).

Important disclaimer:

This press release contains forward-looking statements and estimates that involve risks and uncertainties. The forward-looking statements and estimates contained herein represent the judgement of Eurofins Scientific’ management as of the date of this release. These forward-looking statements are not guarantees for future performance, and the forward-looking events discussed in this release may not occur. Eurofins Scientific disclaims any intent or obligation to update any of these forward-looking statements and estimates. All statements and estimates are made based on the information available to the Company’s management as of the date of publication, but no guarantee can be made as to their validity.